SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-024866
Filing Date
2022-05-09
Accepted
2022-05-09 16:05:26
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159613-8k_augmedix.htm   iXBRL 8-K 33366
2 PRESS RELEASE DATED MAY 9, 2022 ANNOUNCING FIRST QUARTER 2022 FINANCIAL RESULTS ea159613ex99-1_augmedix.htm EX-99.1 66316
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2939
  Complete submission text file 0001213900-22-024866.txt   289619

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE augx-20220509.xsd EX-101.SCH 3033
5 XBRL LABEL FILE augx-20220509_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE augx-20220509_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159613-8k_augmedix_htm.xml XML 3716
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 22904847
SIC: 7389 Services-Business Services, NEC